Buy Axovant Sciences Stock | AXON Stock Price & Latest News | Public
AXON

Axovant Sciences

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About AXON

    Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangli...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$107,69M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.12
    1 Year Low$1.41
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app